Brief: SAGE Therapeutics Announces Research And Development Leadership Transition
04/03/2025 21:49
March 4 (Reuters) - SAGE Therapeutics Inc SAGE.O: SAGE THERAPEUTICS ANNOUNCES RESEARCH AND DEVELOPMENT LEADERSHIP TRANSITION Source text: ID:nBwKPBl7a Further company coverage: SAGE.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sage Therapeutics
See all newsBrief: Supernus Pharmaceuticals Completes Acquisition Of Sage Therapeutics
Sage Therapeutics Inc Reports Results For The Quarter Ended June 30: Earnings Summary
SAGE Therapeutics Q2 revenue rises sequentially
Brief: Supernus Pharmaceuticals Announces Expiration Of Hart-Scott-Rodino Waiting Period For Sage Therapeutics Tender Offer
Sage Therapeutics Inc Expected To Post A Loss Of 95 Cents A Share: Earnings Preview